Abiopharma

News list

Matsuda Masaru 🔴 sold 36.1K shares of Arcutis Biotherapeutics, Inc. (ARQT) at $16.16 Transaction Date: Sep 04, 2025 | Filing ID: 000134

Full text

News bot Sept. 8, 2025, 9:15 p.m.
🔍 Matsuda Masaru (Executive)

Company: Arcutis Biotherapeutics, Inc. (ARQT)

Report Date: 2025-09-04
Transaction Summary:
- Total transactions: 1
- Derivative instruments: 0
- Holdings reported: 0
- Total shares sold: 36,130
Detailed Transactions and Holdings:
- Sold 36,130 shares of Common Stock at $16.156 per share (Direct)
  Date: 2025-09-04 | Code: S | equity_swap_involved: 0 | shares_owned_after: 161,234.00 | transaction_form_type: 4 | Footnotes: F1, F1, F2
Footnotes:
- F1: The transactions reported in this Form 4 were effected pursuant to a 10b5-1 trading plan adopted on June 5, 2025, by the Reporting Person, with a plan end date of September 4, 2026.
- F2: The price reported in Column 4 is a weighted average sale price. The shares were sold in multiple transactions at prices ranging from $15.93 to $16.3787, inclusive. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.
- REMARKS: Reporting Person's title: SVP General Counsel and Corporate Secretary